Boom in drug-coated stents proves elusive

Boom in drug-coated stents proves elusive

By Avery Johnson

The Wall Street Journal Europe

27 Nov 2006



GROWING CONCERNS about devices that open clogged arteries are causing some chest pains on Wall Street. Just a few months ago, many analysts were ebullient about these complex devices called drug-eluting stents, which are implanted into diseased... read more...

Tech Tags: The Wall Street Journal Europe newspaper Corporate News

Bayer uses humor to sell Levitra

Bayer uses humor to sell Levitra

By Geoffrey A. Fowler

The Wall Street Journal Europe

24 Nov 2006



HONG KONG—In the U.S., drug makers typically sell erectile-dysfunction pills with clinical talk or soft-focus romance. Here, Bayer HealthCare is selling Levitra with comic strips. Sales of the prescription drug are soaring in Hong Kong since the unit... read more...

Tech Tags: The Wall Street Journal Europe newspaper Corporate News

Merck looks to traditional remedies with Chi-Med deal

Merck looks to traditional remedies with Chi-Med deal

Marianne Barriaux

The Guardian

20 Nov 2006



Chi-Med, the Aim-listed drug company focused on traditional Chinese medicine, has signed a deal with Germany’s Merck in the latest sign that big pharmaceutical groups are being forced to delve into different areas to find new drugs. The global drugs... read more...

Tech Tags: The Guardian newspaper Financial

Democrat reform drive to hit drugmakers

Democrat reform drive to hit drugmakers

Marianne Barriaux

The Guardian

17 Nov 2006



The Democrats were still in a buoyant mood as they began electing their leadership for Congress yesterday, little more than a week after they won majorities in the House of Representatives and the Senate. But the pharmaceuticals industry on both sides... read more...

Tech Tags: The Guardian newspaper Financial

3M will sell drugs unit in three separate deals

3M will sell drugs unit in three separate deals

By Bob Sechler

The Wall Street Journal Europe

10 Nov 2006



U.S. manufacturing conglomerate 3M Co. will sell its global branded-pharmaceuticals business in three deals totaling nearly $2.1 billion, seven months after announcingitwantedtoshedtheslowgrowth unit. GracewayPharmaceuticals Inc. of the U.S. has... read more...

Tech Tags: The Wall Street Journal Europe newspaper Corporate News

Novartis puts D in China

Novartis puts D in China

By Nicholas Zamiska

The Wall Street Journal Europe

06 Nov 2006



SHANGHAI— Novartis AG plans to announce today it will build a pharmaceutical research-and-development center in China, as the global drug industry strives to harness the country’s talent pool to replenish its product pipeline at lower cost while... read more...

Tech Tags: The Wall Street Journal Europe newspaper Leading The News Index To Businesses Index To Peop